1 / 1

DOES HIV/ HEPATITIS COINFECTION AFFECT PEOPLE ACCESSING CARE FOR HIV? Suchitra JB, Nirmala R

FREEDOM FOUNDATION 180 HENNUR CROSS, BANGALORE E-mail: freedomg2@dataone.in , suchitra_preetham@yahoo.com. DEMOGRAPHIC CHARACTERISTICS OF THE STUDY POPULATION. BACKGROUND

chung
Download Presentation

DOES HIV/ HEPATITIS COINFECTION AFFECT PEOPLE ACCESSING CARE FOR HIV? Suchitra JB, Nirmala R

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FREEDOM FOUNDATION 180 HENNUR CROSS, BANGALORE E-mail: freedomg2@dataone.in, suchitra_preetham@yahoo.com DEMOGRAPHIC CHARACTERISTICS OF THE STUDY POPULATION BACKGROUND Coinfection with Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) are known to be common in patients with HIV infection. It is also known that timely diagnosis and clinical staging of chronic hepatitis infection are critical in the management of HIV coinfected patients. However HBV and HCV are not routinely tested for in a resource poor setting like India due to the costs associated with the testing and treatment. AIM OF THE STUDY 1.Prevalence of Hepatitis B and Hepatitis C virus coinfection in HIV infected individuals . 2.The correlation of LEE (Liver Enzyme Elevation) and Hepatitis coinfection. 3. Impact of LEE on mortality . DOES HIV/ HEPATITIS COINFECTION AFFECT PEOPLE ACCESSING CARE FOR HIV?Suchitra JB, Nirmala R MATERIALS AND METHODSSTUDY DESIGN: Retrospective, Descriptive, Qualitative study.SUBJECTS: Diagnosed HIV positive patients (n=100) visiting the HIV clinic for initiation of Highly Active Anti-Retroviral Treatment (HAART), were included in the study. LABORATORY MARKERS: HBsAg ,anti-HCV antibodies and Liver Function Tests (LFTs) among other tests done as routine for initiation of HAART.STATISTICAL ANALYSIS: Chi-square and Fisher exact test CONCLUSIONSHIV infected patients co-infected with HBV or HCV were at considerably higher risk of developing LEE compared with patients without co-infection. REFERENCES1.Den Brinker M, Wit FW, Wertheim-van DPM, Jurriaans S, Weel J, Van Leeuwen Ret al.,Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS 2000;14: 2895-902.2.Yachimski P, Chung RT. Update on Hepatitis B and C Coinfection in HIV. Curr Infect Dis Rep 2005; 7: 299-308. Testing for Hepatitis coinfection among HIV infected individuals is necessary as the prevalence rate is on the rise. The diagnosis will help influence treatment initiation, management and complications associated with Hepatitis, HIV coinfection.

More Related